MCKESSON CORP — Federal Records

co_sos 1 records

CO Business: MCKESSON CORPORATION 1994-09-20

FPC | Status: Good Standing | Irving, TX

View Source

courtlistener_docket 4 records

Northern v. McKesson Corp. 2026-05-28

Federal docket 2:26-cv-01964 (caed); matched party 'McKesson Corp.'

View Source

Northern v. McKesson Corporation 2026-05-28

Federal docket 2:26-at-00910 (caed); matched party 'McKesson Corporation'

View Source

Hampton v. McKesson Corporation 2026-04-21

Federal docket 3:26-cv-00093 (msnd); matched party 'McKesson Corporation'

View Source

McKesson Corporation v. Home Care Rx, Inc. 2026-03-30

Federal docket 8:26-cv-00777 (cacd); matched party 'McKesson Corporation'

View Source

Department of Justice 10 records

DOJ: McKesson Agrees to Pay $1 Million to Resolve Recordkeeping Violations under the Controlled Substances Act 2022-03-14

McKesson Corporation (McKesson) agreed to pay a $1 million civil penalty to resolve alleged Controlled Substances Act (CSA) recordkeeping violations, the Department of Justice announced today. The res...

View Source

DOJ: McKesson Agrees to Pay $1 Million to Resolve Recordkeeping Violations under the Controlled Substances Act 2022-03-14

Memphis, TN - McKesson Corporation (McKesson) agreed to pay a $1 million civil penalty to resolve alleged Controlled Substances Act (CSA) record-keeping violations, the Department of Justice announced...

View Source

DOJ: McKesson Agrees To Pay Record $150 Million Settlement For Failure To Report Suspicious Orders Of Pharmaceutical Drugs 2017-01-19

LEXINGTON, Ky. – McKesson Corporation (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty for alleged violations of the Cont...

View Source

DOJ: McKesson Agrees to Pay Record $150 Million Settlement for Failure to Report Suspicious Orders of Pharmaceutical Drugs 2017-01-18

LOS ANGELES – McKesson Corporation, one of the nation’s largest distributors of pharmaceutical drugs, has agreed to pay a record $150 million civil penalty for alleged violations of the Controlled Sub...

View Source

DOJ: McKesson Agrees to Pay Record $150 Million Settlement for Failure to Report Suspicious Orders of Pharmaceutical Drugs 2017-01-17

McKesson Corporation (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty for alleged violations of the Controlled Substances...

View Source

DOJ: McKesson Agrees To Pay Record $150 Million Settlement For Failure To Report Suspicious Orders Of Pharmaceutical Drugs 2017-01-17

Tampa, FL – McKesson Corporation (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty for alleged violations of the Controlle...

View Source

DOJ: McKesson Agrees to Pay Record $150 Million Settlement for Failure to Report Suspicious Orders of Pharmaceutical Drugs 2017-01-17

BOSTON – McKesson Corporation, one of the nation’s largest distributors of pharmaceutical drugs to pharmacies and other health care providers, agreed to pay a record $150 million civil penalty for all...

View Source

DOJ: McKesson agrees to pay record $150 million settlement for failure to report suspicious orders of pharmaceutical drugs 2017-01-17

WHEELING, WEST VIRGINIA – McKesson Corporation (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty for alleged violations of...

View Source

DOJ: McKesson Agrees To Pay Record $150 Million Settlement For Failure To Report Suspicious Orders Of Pharmaceutical Drugs 2017-01-17

WASHINGTON – McKesson Corp. (McKesson), one of the nation’s largest distributors of pharmaceutical drugs, has agreed to pay a record $150 million civil penalty for alleged violations of the Controlled...

View Source

DOJ: McKesson Agrees to Pay Record $150 Million Settlement for Failure to Report Suspicious Orders of Pharmaceutical Drugs

...distributors of pharmaceutical drugs, agreed to pay a record $150 million civil penalty...(CSA). The settlement resolves allegations that McKesson failed to design and...distributors of pharmaceuti...

View Source

fda 5 records

FDA Drug Recall: UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, 2026-02-18

Class I — Temperature Abuse. 116 cartons with specific serial numbers of Lot 2199821, were stored incorrectly in a controlled room temperature environment instead of the required refrigerated environm...

View Source

FDA Drug Recall: Inflectra (infliximab-dyyb), For injection, 100mg per vial, packaged in 10 mL si 2025-02-05

Class II — cGMP Deviations: Product intended for quarantine was inadvertently distributed.

View Source

FDA Drug Recall: CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2% 2024-02-28

Class II — CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.

View Source

FDA Drug Recall: Megestrol Acetate Oral Suspension, USP 400 mg/mL, 10 mL (10 mL UD cups in boxes 2018-09-12

Class II — Supterpotent Drug

View Source

FDA Drug Recall: Amiodarone HCl Injection, 450 mg/9 mL (50 mg per mL), 9 mL Single-Use Vial, Rx o 2014-10-15

Class II — Temperature Abuse: One shipment was inadvertantly stored refrigerated rather than the labeled room temperature recommendation at McKesson Medical-Surgical Inc., one of the distributing whol...

View Source

fda_adverse 1 records

FDA AE Manufacturer: McKesson

Drug adverse event reporter — Product: ACETAMINOPHEN

View Source

ftc_enforcement 2 records

McKesson Corp. and AmeriSource Health Corp 1998-07-31

FTC live enforcement action FY1998; matched respondent 'McKesson Corp.'

View Source

McKesson Corp. / AmeriSource Health 1998-03-03

FTC merger enforcement action FY1998 matter 9810025; matched respondent 'McKesson Corp.'

View Source

lobbying 5 records